STAGE IIA LUNG CANCER AJCC V8
Clinical trials for STAGE IIA LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIA LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy shows promise in stopping lung cancer before it starts
Prevention CompletedThis study tested whether the immunotherapy drug pembrolizumab can prevent lung cancer from coming back in 45 people with early-stage (stage I-II) non-small cell lung cancer or high-risk lung nodules. Participants received pembrolizumab to help their immune system attack any rema…
Matched conditions: STAGE IIA LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Apr 30, 2026 15:50 UTC
-
Tiny heart monitor spies hidden damage during cancer radiation
Knowledge-focused CompletedThis study looked at how radiation treatment for lung or esophageal cancer affects the heart. 24 patients received a small implanted heart monitor to track changes that might otherwise go unnoticed. The goal was to find early signs of heart problems so they can be treated sooner …
Matched conditions: STAGE IIA LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:01 UTC